See analyst estimates and all valuation multiples for BioTech
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $952B | 15.2x | 33.8x | |
| $537B | 5.7x | 15.1x | |
| $458B | 7.5x | 17.8x | |
| $274B | 5.0x | 12.1x | |
| $272B | 4.2x | 9.3x | |
| $247B | 5.6x | 22.2x | |
| $216B | 6.0x | 12.2x | |
| $193B | 3.1x | 7.8x | |
| $175B | 7.2x | 22.9x | |
| $167B | 5.7x | 10.6x | |
| $141B | 2.9x | 7.8x | |
| $117B | 2.7x | 8.0x | |
| $110B | 9.2x | 21.3x | |
| $84.8B | 10.6x | 20.9x | |
| $79.5B | 1.5x | 7.1x | |
| $72.2B | 5.1x | 14.3x | |
| $71.0B | 2.9x | 10.0x | |
| $70.4B | 2.4x | 9.0x | |
| $68.5B | 4.3x | 12.7x | |
| $57.5B | 6.1x | 14.0x | |
| $54.2B | 6.4x | 21.0x | |
| $53.8B | 11.5x | 38.5x | |
| $51.1B | 14.0x | 76.0x | |
| $31.5B | 14.4x | -98.3x | |
| $29.0B | 14.0x | 36.2x | |
| $26.9B | 1.9x | 6.5x | |
| $26.6B | 2.1x | 8.8x | |
| $26.3B | 2.4x | 12.0x | |
| $26.1B | 7.6x | 24.8x | |
| $23.7B | 7.9x | 8.2x | |
| $21.0B | 7.9x | 32.8x | |
| $20.7B | 60.5x | 38.6x | |
| $18.0B | 9.5x | 67.1x | |
| $12.3B | 13.9x | -33.1x | |
| $11.0B | 2.5x | 6.6x | |
| $10.6B | 1.6x | 8.7x | |
| $10.3B | 3.1x | 7.4x | |
| $10.3B | 4.4x | 11.1x | |
| $10.2B | 4.9x | 13.5x | |
| $10.0B | 1.6x | 12.7x | |
| $9.6B | 7.9x | 22.5x | |
| $9.4B | 3.0x | 12.2x | |
| $9.0B | 497.9x | -13.6x | |
| $7.9B | n/a | n/a | |
| $7.4B | 11.9x | -44.1x | |
| $7.2B | n/a | -17.8x | |
| $7.0B | 94.6x | -4737.8x | |
| $6.9B | 14.6x | 48.4x | |
| $6.8B | 127.3x | -21.6x | |
| $6.5B | 103474.3x | n/a | |
| $6.4B | 16.6x | 38.9x | |
| $6.3B | 2.1x | 9.3x | |
| $6.2B | 2.0x | 8.3x | |
| $6.2B | n/a | -23.4x | |
| $5.6B | n/a | n/a | |
| $5.4B | 65.2x | -42.8x | |
| $5.2B | 8.8x | 38.9x | |
| $5.2B | 8.8x | 26.8x | |
| $5.0B | 1.8x | 4.9x | |
| $4.9B | 5.8x | 28.8x | |
| $4.8B | 5.7x | 19.9x | |
| $4.8B | 2.7x | 5.4x | |
| $4.8B | 1.4x | 8.4x | |
| $4.8B | 9.3x | 24.4x | |
| $4.7B | 3.1x | 8.5x | |
| $4.6B | 3.8x | 15.3x | |
| $4.6B | 3.3x | 10.0x | |
| $4.6B | n/a | -9.1x | |
| $4.5B | n/a | -11.6x | |
| $4.3B | 4.6x | 13.3x | |
| $4.2B | 6.0x | n/a | |
| $4.2B | n/a | n/a | |
| $4.0B | 3.9x | 17.8x | |
| $3.9B | 3.1x | 18.1x | |
| $3.7B | 404.7x | -6.3x | |
| $3.7B | 3.9x | 16.3x | |
| $3.7B | 3.6x | -27.9x | |
| $3.5B | 2.1x | 10.3x | |
| $3.5B | 13.7x | 33.7x | |
| $3.3B | 4.1x | 81.1x | |
| $3.2B | 4.7x | 14.5x | |
| $3.1B | n/a | n/a | |
| $3.0B | 3.4x | 13.8x | |
| $2.8B | 51.3x | -10.8x | |
| $2.8B | 4.0x | 16.9x | |
| $2.5B | 4.0x | 13.3x | |
| $2.5B | 3.5x | 19.0x | |
| $2.4B | 5.6x | -80.4x | |
| $2.3B | 1.7x | 11.2x | |
| $2.3B | 38.2x | -68.3x | |
| $2.2B | 3.0x | 15.3x | |
| $2.1B | 1.7x | 8.8x | |
| $2.1B | 5.6x | 16.3x | |
| $2.1B | 1.9x | 9.7x | |
| $2.1B | 9.3x | 35.6x | |
| $2.0B | 0.8x | 5.9x | |
| $1.9B | 2.4x | 9.0x | |
| $1.9B | 1.8x | 12.2x | |
| $1.8B | 4.5x | 12.0x | |
| $1.5B | 3.6x | 11.2x |